Showing results (291-300 of 39,526) with videos related to

Sort By:
Pageof 3,953
Blood|February 26, 2025
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphomaVan Thuy Mai Nguyen, Hiroe Namba, Hayley Porter, et al.
Blood|February 19, 2025
How I treat patients who are refractory to platelet transfusionsSusan Nahirniak, Veera Nadarajan, Simon J Stanworth
Blood|February 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMTCarmelo Gurnari, Marie Robin, Lionel Adès, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
Blood|November 14, 2025
Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulationTianyi Ling, Cristiana O'Brien, Jonathan St-Germain, et al.
Blood|November 14, 2025
Highly discriminative globin gene activation by the non-canonical BAF chromatin remodeling complexAbhirup Bagchi, Sindhu Billakanti, Vanessa Shehu, et al.
Blood|November 5, 2025
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapySven Turkalj, Felix A Radtke, Bilyana Stoilova, et al.
Blood|October 8, 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell TransplantationBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Blood|October 8, 2025
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasoneLuca Bertamini, Cathelijne Fokkema, Paula Rodriguez-Otero, et al.
Blood|October 16, 2025
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma modelsKodandaram Pillarisetti, Danlin Yang, Leopoldo Luistro, et al.
Pageof 3,953